TABLE 6.
Proportional odds models for E. coli MIC responses for two antimicrobials
| Antimicrobial | Independent variable | Beta | CI
|
Pa | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Gentamicin | Continuous tylosin | 0.56 | −0.01 | 1.13 | 0.0534 |
| Continuous CTC | 0.59 | −0.11 | 1.30 | 0.0989 | |
| Pulse tylosin | 0.18 | −0.59 | 0.95 | 0.6456 | |
| Pulse CTC | 0.56 | −0.11 | 1.22 | 0.0986 | |
| Period 2 | 1.70 | 1.21 | 2.19 | 0.0000* | |
| Continuous tylosin*period 2 | −1.12 | −1.77 | −0.47 | 0.0011* | |
| Continuous CTC*period 2 | −1.09 | −1.97 | −0.20 | 0.0167* | |
| Pulse tylosin*period 2 | −1.00 | −1.70 | −0.31 | 0.0055* | |
| Pulse CTC* period 2 | −1.21 | −2.00 | −0.43 | 0.0030* | |
| Streptomycin | Continuous tylosin | −0.34 | −0.85 | 0.16 | 0.1801 |
| Continuous CTC | −0.88 | −1.45 | −0.31 | 0.0020* | |
| Pulse tylosin | −0.30 | −0.98 | 0.38 | 0.3794 | |
| Pulse CTC | −0.56 | −1.14 | 0.02 | 0.0575 | |
| Period 2 | −2.09 | −2.72 | −1.46 | 0.0000* | |
| Continuous tylosin*period 2 | 0.84 | 0.03 | 1.66 | 0.0431* | |
| Continuous CTC*period 2 | 1.85 | 1.00 | 2.70 | 0.0001* | |
| Pulse tylosin*period 2 | 1.21 | 0.25 | 2.17 | 0.0144* | |
| Pulse CTC*period 2 | 1.15 | 0.24 | 2.06 | 0.0141* | |
*, significant at P = 0.05 level.